Master the R Series Bootcamp - February 6, 13, 20, and 27. Registration is now open.

What do you mean my $5 million grant application was only awarded $244,000?

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

It’s always gratifying to learn you have landed a grant. Last week was no exception– I learned we landed a grant jointly sponsored by NIH and IRS that was submitted last July. Basically the FOA offered grant money or tax credit to companies that are producing new therapies or attempting to reduce health care costs. Our client was a medical device company with fewer than 250 employees, so they qualified for up to $5 million.

I got the email that we were funded—for $244,479.24. Excuse me? Not that I’m ungrateful, but what about the $5mil? I had written the narrative myself de novo and I knew it was “beast”, as my 16-year old stepdaughter would say. So what went wrong?

Well, nothing. At least, not with the grantwriting. After inquiring I learned that no grantee received more than that dollar amount. The FOA was funded by a set-aside; Faced with a finite pot of money and far more excellent qualifying projects than they could fund, the sponsors opted to reduce the size of the awards in order to fund more projects.

If you have gotten a federal grant funded over the past few years without a budget reduction, consider yourself lucky. Over and over, I have seen R- and K-series grants come back with reductions in the dollar amount and time period. It is common these days to see a five-year, $1.5 million R01 funded for three or four years, $1M, with (at least) one of the Specific Aims removed.

How can you fold this information into your approach to grantwriting? Write each Specific Aim so that it stands alone. Don’t let any one Aim rely upon another. If your grant hovers around the funding line, make it easy for the funding agency to slice off one of your Aims, drop your dollar amount and timeframe, and fund you (and others) near the funding line. If you don’t, your grant may be passed over for one that scored worse, but for which they can easily eliminate an Aim!

Dr. Meg Bouvier

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
Related posts

You May Also Be Interested In

Bouvier Grant Group logo white
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH October 2023 Newsletter cover